TransEnterix Inc. | |
Stock Exchange | NYSE |
EPS |
$0.4 |
Market Cap |
$284.71 M |
Shares Outstanding |
217.34 M |
Public Float |
179.38 M |
TransEnterix Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
208.97 M |
Public Float |
182.26 M |
Address |
635 Davis Drive Morrisville North Carolina 27560 United States |
Employees | - |
Website | http://www.transenterix.com |
Updated | 07/08/2019 |
TransEnterix, Inc. operates as a development stage medical device company. It focuses on research, development and sale of medical device robotics to improve minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. |